Neurodevelopmental effects of opioids in preterm infants - A systematic review and meta-analysis of randomised and

Maya Rakshasbhuvankar1, Chandra Rath2, Sachin Agrawal2

  • 1General Paediatrics, Perth Children's Hospital, Western Australia, Australia; Neonatology, King Edward Memorial Hospital for Women, Perth, Western Australia, Australia.

Early Human Development
|August 20, 2025
PubMed

Insights

Opioid use in preterm infants does not appear to increase neurodevelopmental impairment risk. However, evidence is very limited, with some studies suggesting potential negative impacts on motor skills.

Area of Science:

  • Neonatalogy
  • Developmental Pediatrics
  • Pharmacology

Background:

  • Opioids are frequently administered to preterm infants for pain and distress management in neonatal intensive care units.
  • Concerns exist regarding the potential adverse effects of opioid exposure on infant neurodevelopment.

Purpose of the Study:

  • To systematically review randomized controlled trials (RCTs) and observational studies (OSs) investigating the impact of opioids on neurodevelopmental outcomes in preterm infants.

Main Methods:

  • A systematic review adhering to Cochrane Collaboration guidelines was performed.
  • Included randomized controlled trials (RCTs) and observational studies (OSs).
  • Quantitative synthesis (pooling) was used where possible; qualitative synthesis for other data.

Main Results:

  • The review encompassed 16 studies (13 OSs, 3 RCTs) with 3173 infants.
  • No increased risk of neurodevelopmental impairment was found (very low certainty evidence).
  • Lower motor scores were observed in opioid-exposed infants at 2-3 years; qualitative analysis showed variable effects of opioids.

Conclusions:

  • The current evidence regarding opioid effects on preterm infant neurodevelopment is inconclusive.
  • The certainty of the available evidence is rated as 'very low'.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
426
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K